DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Pharmacogenomics (PGx) Market Analysis: Focus on Ecosystem Players, Therapeutic Applications, and Geography - Estimation & Forecast 2016-2022" report to their offering.
The global PGx market is expected to grow over $14.85 billion by 2022. The market growth is propelling due to factors such as: rising usage in drug discovery processes, increasing demand for pharmacogenomics & precise drugs, technological innovation and advancement, increasing genetic disorders/abnormalities, and government support and regulations.
The market growth is gradually gaining speed as large number of government initiatives and research & development programs have been launched in the last few years. Advancement and innovation of new healthcare technologies such as next generation sequencing, High Throughput Screening (HTS), and Digital PCR are developing the platform for the growth of Pharmacogenomics (PGx) market.
With the increasing research and development process, it has been estimated that the demand for precision drugs will escalate in the coming future and thus result in the high growth of pharmaceutical & biotech companies.
The primarily reason attributed to the growth of the therapeutics market is due to the increase in cancer cases, cardiac diseases, skin diseases, HIV, mental disorders, and other genetic disorders. However, the infectious diseases are gaining more traction as compared to other diseases as the numbers of patients suffering from these diseases are increasing at a very rapid growth rate all over the world specifically in African and Asian countries. This segment is growing at a CAGR of 17.49% from 2016 to 2022.
Key Topics Covered:
1. Report Overview
2. Executive Summary
3. Market Overview
4. Competitive Insights
5. Industry Analysis
6. Global Pharmacogenomics Market By Technology
7. Global Pharmacogenomics Market By Ecosystem Players
8. Global Pharmacogenomics Market By Therapeutic Applications
9. Global Pharmacogenomics Market By Geography
10. Company Overview
Companies Mentioned:
- Abbott Laboratories
- Affymetrix, Inc.
- Assurex Health, Inc.
- Astrazeneca
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- Pfizer, Inc.
- Qiagen, Inc.
- Roche Holding Ag-Br
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
-
Transgenomic, Inc.
For more information visit http://www.researchandmarkets.com/research/lnzr2c/global
